These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 21593295)
1. The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy: a pilot randomized controlled trial. Pakarinen TK; Laine HJ; Mäenpää H; Mattila P; Lahtela J Diabetes Care; 2011 Jul; 34(7):1514-6. PubMed ID: 21593295 [TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Jude EB; Selby PL; Burgess J; Lilleystone P; Mawer EB; Page SR; Donohoe M; Foster AV; Edmonds ME; Boulton AJ Diabetologia; 2001 Nov; 44(11):2032-7. PubMed ID: 11719835 [TBL] [Abstract][Full Text] [Related]
3. Effect of immobilization, off-loading and zoledronic acid on bone mineral density in patients with acute Charcot neuroarthropathy: a prospective randomized trial. Pakarinen TK; Laine HJ; Mäenpää H; Kähönen M; Mattila P; Lahtela J Foot Ankle Surg; 2013 Jun; 19(2):121-4. PubMed ID: 23548455 [TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Selby PL; Young MJ; Boulton AJ Diabet Med; 1994; 11(1):28-31. PubMed ID: 8181248 [TBL] [Abstract][Full Text] [Related]
5. Diabetes and acute Charcot neuroarthropathy--a call for heightened vigilance. Iheonunekwu N; Ibrahim TM; Ojuro I Niger J Med; 2010; 19(2):239-40. PubMed ID: 20642098 [No Abstract] [Full Text] [Related]
6. Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus. Das L; Rastogi A; Jude EB; Prakash M; Dutta P; Bhansali A PLoS One; 2021; 16(11):e0259224. PubMed ID: 34748565 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Arthrodesis with Total Contact Casting for Midfoot Ulcerations Associated with Charcot Neuroarthropathy. Wang Y; Zhou J; Yan F; Li G; Duan X; Pan H; He J Med Sci Monit; 2015 Jul; 21():2141-8. PubMed ID: 26205524 [TBL] [Abstract][Full Text] [Related]
15. Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial. Crawford BA; Kam C; Pavlovic J; Byth K; Handelsman DJ; Angus PW; McCaughan GW Ann Intern Med; 2006 Feb; 144(4):239-48. PubMed ID: 16490909 [TBL] [Abstract][Full Text] [Related]
16. Risk factors of charcot neuroarthropathy development in patients with type 2 diabetes. Nehring P; Mrozikiewicz-Rakowska B; Maroszek P; Sobczyk-Kopcioł A; Krzyżewska M; Płoski R; Karnafel W Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):31-4. PubMed ID: 24203651 [TBL] [Abstract][Full Text] [Related]
17. Infrared dermal thermometry is highly reliable in the assessment of patients with Charcot neuroarthropathy. Dallimore SM; Puli N; Kim D; Kaminski MR J Foot Ankle Res; 2020 Sep; 13(1):56. PubMed ID: 32928270 [TBL] [Abstract][Full Text] [Related]
18. Investigating the Use of Denosumab in the Treatment of Acute Charcot Neuroarthropathy. Shofler D; Hamedani E; Seun J; Sathananthan A; Katsaros E; Liggan L; Kang S; Pham C J Foot Ankle Surg; 2021; 60(2):354-357. PubMed ID: 33472754 [TBL] [Abstract][Full Text] [Related]
19. Role of body mass index in acute charcot neuroarthropathy. Ross AJ; Mendicino RW; Catanzariti AR J Foot Ankle Surg; 2013; 52(1):6-8. PubMed ID: 23260985 [TBL] [Abstract][Full Text] [Related]
20. The role of genetic factors and monocyte-to-osteoclast differentiation in the pathogenesis of Charcot neuroarthropathy. Kloska A; Korzon-Burakowska A; Malinowska M; Bruhn-Olszewska B; Gabig-Cimińska M; Jakóbkiewicz-Banecka J Diabetes Res Clin Pract; 2020 Aug; 166():108337. PubMed ID: 32707214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]